STTK

STTK

USD

Shattuck Labs Inc. Common Stock

$1.930-0.030 (-1.531%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.960

最高价

$2.075

最低价

$1.858

成交量

0.10M

公司基本面

市值

92.5M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.81M

交易所

NMS

货币

USD

52周价格范围

最低价 $0.692当前价 $1.930最高价 $2.705

相关新闻

Analyst Upgrades

Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4

Wedbush analyst David Nierengarten initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.

查看更多
Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4
GlobeNewswire

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma

查看更多
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
GlobeNewswire

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to

查看更多
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease